The Chief Executive Officer of Nkarta Inc. is Paul J. Hastings, an experienced biopharmaceutical executive who guides the company's strategic focus on natural killer cell therapies for cancer and autoimmune diseases. In his leadership role, he manages corporate governance, clinical trial advancement, and investor relations. His executive oversight is centered on steering the company's proprietary engineered cell therapy programs through rigorous clinical development and regulatory evaluation phases.